Long-Term Clinical Outcome After Postchemotherapy Retroperitoneal Lymph Node Dissection In Men With Residual Teratoma
Mon, 19 Feb 2007 06:00 PM EST
... UroToday.com- Patient with residual masses after chemotherapy for mixed germ cell tumors should undergo retroperitoneal lymphadenectomy to address the measurable incidence of teratoma (40%) and viable cancer in the retroperitoneum. The long-term pattern of recurrence and recommended surveillance strategy of these patients has not been well defined. [click link for full article] ...
Related Topics
- Lymph Nodes
- Long Term Care
- Biopsy
- Clinical Trials
- Mucocutaneous lymph node syndrome
- Acute Care
- Men's Health
- Long Term Care/ltc
- Long-term incontinence or urinary retention
- Complications due to long-term catheter use
- Vegetative state (long-term coma)
- Chronic (long-term) kidney failure
- Weak bones (osteomalacia) and osteoporosis (due to very long-term cholestasis)
- Nursing Home Care
- Disabilities
- Pharmacology
- Multiple endocrine neoplasia type 2
- Psychopharmacology
- Cat Scratch Disease
- Teratoma

Not Signed In -

